CompletedNot Applicable

Quality of Life in Patients With Congenital Afibrinogenemia

United States, Algeria, Canada250 participantsStarted 2016-06

Plain-language summary

The aim of this observational study is to evaluate the quality of life in patients with congenital afibrinogenemia using the Haemo-QoL SF for kids and the Haem-A-QoL for adult patients.

Who can participate

Age range8 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Congenital afibrinogenemia confirmed by biology (absence of circulating fibrinogen) and genotype Exclusion Criteria: * Lack of participant's consent * Patient unable to understand the questionnaire

What they're measuring

The influence of the afibrinogenemia on the patients' quality of life assessed by the Haemo-QoL SF questionnaire (for children) and the Haem-A-QoL questionnaire (for adult)

Timeframe: At inclusion

Trial details

NCT IDNCT03484065

SponsorUniversity Hospital, Geneva

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-07

View on ClinicalTrials.gov More Afibrinogenemia, Congenital trials